Abstract

The incidence of renal cell carcinoma (RCC) has been rising by 2.3 to 4.3% every year over the past three decades. Previously, RCC has been known as the internist's tumor; however, it is now being called the radiologist's tumor because 2÷3 are now detected incidentally on abdominal imaging. We compared patients who were treated toward the end of the 20th century to those treated during the beginning of the 21st century with regard to RCC size and type of surgical treatment. The study included 226 patients. For analysis of tumor size, we considered a cut point of <4 cm and>4 cm. For analysis of type of surgery performed, we considered radical and partial nephrectomy. After the turn of the century, there was a reduction of 1.57±0.48 cm in the size of the RCC that was operated on. Nephron sparing surgeries were performed in 17% of the cases until the year 2000, and 39% of the tumors were <4 cm. From 2001, 64% of the tumors measured<4 cm and 42% of the surgeries were performed using nephron sparing techniques. Mean tumor size was 5.95 cm (±3.58) for the cases diagnosed before year 2000, and cases treated after the beginning of 21st century had a mean tumor size of 4.38 cm (±3.27). Compared with the end of the 20th century, at the beginning of the 21st century due to a reduction in tumor size it was possible to increase the number of nephron sparing surgeries.

Highlights

  • The incidence of the renal cell carcinoma (RCC) has been increasing by 2.3 to 4.3% per year over the last three decades in the United States [1]

  • Since Bell’s classic study [2], the first to relate RCC size to prognosis, there has been a variety of stage modifications in the TNM system related to tumor size variations

  • The goal of this study was to compare RCC size between cases treated during the end of the 20th century to those treated during the beginning of the 21st century

Read more

Summary

Introduction

The incidence of the renal cell carcinoma (RCC) has been increasing by 2.3 to 4.3% per year over the last three decades in the United States [1]. Approximately 1/3 of the patients who have been diagnosed with RCC will die due to progression to metastatic disease [1]. Since Bell’s classic study [2], the first to relate RCC size to prognosis, there has been a variety of stage modifications in the TNM system related to tumor size variations. This information suggests that tumor growth significantly influences the prognosis of this lethal disease. The majority of studies that have reported a large number of patients indicate that the stratification size related to RCC prognosis is between 4 and 5 cm [3,4]. The Mayo Clinic study showed that patients who underwent radical nephrectomy presented a higher possibility to have elevated serum creatinine levels and proteinuria higher than 2.0 ng/mL [8]

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call